Aflac Incorporated (AFL)

In the past six months, Aflac's stock price has seen some fluctuations. As of July 14, 2025, Aflac's share price was $102.67, representing an increase of 9.96% from July 15, 2024. First Quarter 2025 results showed total revenues of $3.4 billion, down from $5.4 billion in Q1 2024, with net earnings dropping significantly to $29 million. Third Quarter 2024 results reported net losses of $93 million. In the first quarter of 2025, Aflac repurchased 8.5 million common shares and declared a second-quarter dividend of $0.58 per share. Aflac disclosed a cybersecurity incident detected on June 12, 2025, involving unauthorized access. As of July 3, 2025, analysts generally have a "Hold" consensus for Aflac.

Information directly detailing the demand seasonality for Aflac's products and services is not explicitly available. The insurance industry can be influenced by open enrollment periods for employer-sponsored benefits. Aflac's strategy includes product launches and updates, which can drive sales at specific times. Demand for supplemental insurance can be influenced by economic conditions and consumer awareness of out-of-pocket healthcare costs. July has historically been a "green month" for AFL. The long-term nature of the insurance business generally implies a more stable demand compared to highly seasonal consumer goods.

Aflac, Inc. is an American insurance company and a leading provider of supplemental health and life insurance products, founded in 1955 and headquartered in Columbus, Georgia. Aflac operates primarily in the United States and Japan, offering financial protection to policyholders by paying cash benefits for covered accidents or illnesses. The company's product portfolio includes accident, cancer/specified disease, dental, vision, disability, hospital confinement indemnity, hospital confinement sickness indemnity, hospital intensive care, life, lump sum cancer, lump sum critical illness, long-term care, group life and disability products, and pet insurance. Aflac is recognized as the number one provider of supplemental health insurance products in the U.S. and the leading provider of cancer and medical insurance in Japan, distributing its products through independent distributors, agents, brokers, and direct-to-consumer channels.

Aflac's primary geographic footprint is concentrated in the United States and Japan. The Japanese market has historically been a significant contributor to Aflac's revenue and profits, with Aflac Japan generating a substantial portion of the company's total adjusted revenues. Its global footprint is considered limited compared to traditional insurance companies.

Aflac has generally maintained a strong brand reputation, recognized for its financial protection services and commitment to policyholders. Aflac has been included in the World's Most Ethical Companies by Ethisphere for 18 consecutive years and has been recognized as one of the World's Most Admired Companies by Fortune for 23 years. Aflac has been included in Bloomberg's Gender-Equality Index for four consecutive years. In June 2025, Aflac disclosed a cybersecurity incident involving unauthorized access, leading to investigation alerts regarding potential breaches of fiduciary duties and compromised customer data.

Aflac's ownership structure includes institutional, retail, and individual investors. Institutions hold a significant portion of Aflac's shares, with estimates ranging from approximately 0.73% to 69% of the company's stock. Major institutional owners include Japan Post Holdings Co., Ltd., Vanguard Group Inc., and BlackRock, Inc. Retail investors hold a substantial percentage of Aflac's stock, with one source indicating approximately 64.45%. Individual insiders own less than 1% of the company. In the past three months, Aflac insiders have primarily sold shares.